Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Advanced Breast Cancer Therapies, and Cancer-related Molecular Pathways.
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Trial Watch: Immunotherapy plus radiation therapy for oncological indications
Consensus guidelines for the detection of immunogenic cell death
Classification of current anticancer immunotherapies